Log In
BCIQ
Print this Print this
 

PRCN-408

  Manage Alerts
Collapse Summary General Information
Company Neuralgene
Description 
Molecular Target
Mechanism of ActionGene therapy
Therapeutic ModalityGene therapy
Latest Stage of DevelopmentDiscovery
Standard IndicationAge-related macular degeneration (AMD)
Indication DetailsPrevent macular degeneration
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today